Shortage Within A Shortage: Baxter Adjusts Allocation Of I.V. Products As Shortage Drives Demand
This article was originally published in The Pink Sheet Daily
Executive Summary
Baxter cancels all old orders of I.V. solution products as shortage strikes up demand; company maintains initial increased demand sparked shortage, despite FDA manufacturing warning letters.